Accuray Inc (NQ: ARAY )
5.100 USD +0.020 (+0.39%) Streaming Delayed Price Updated: 10:43 AM EST, Mar 8, 2021 Add to My Watchlist
Press releases about Accuray Inc
New Data Demonstrating TomoTherapy® System Adaptive Capabilities and Workhorse Reliability Presented at Leading Scientific Meeting for Medical Physicists
August 03, 2016
Clinical Research Also Showcases Innovative Approaches to Expanding TomoTherapy Platform Functionality
Accuray Retires Remaining 3.75% Convertible Debt
August 01, 2016
Accuray Incorporated (NASDAQ: ARAY) announced today the Company has settled the remaining principal amount and accrued interest thereon of the 3.75% Convertible Senior Notes (the "2016 Notes"). The...
TomoTherapy® System Provides Favorable Cosmetic Outcomes Without Compromising Efficacy in Low-Risk Breast Cancer Patients
July 20, 2016
Accuray Incorporated (NASDAQ: ARAY) announced today preliminary results from a prospective, phase II trial evaluating once-daily accelerated partial breast irradiation (APBI) in patients treated with...
Accuray Products Continue to Receive Highest Composite User Satisfaction Ratings in Latest MD Buyline Report
July 14, 2016
Accuray Incorporated (NASDAQ: ARAY) will report results for its fiscal fourth quarter and full year ended June 30, 2016 on Wednesday, August 17, 2016 after the market close. Management will host a...
Technical Coverage on Medical Appliances & Equipment Stocks - Edwards Lifesciences, Stryker, Accuray, and ABIOMED
July 05, 2016
Accuray Receives 510(k) FDA Clearance for the Radixact™ Image-Guided Radiation Therapy Platform and Integrated Software
June 26, 2016
Next Generation "Smart" System Enables Clinicians to Provide Highly Precise Treatment, Efficiently, for More Patients, Every Day
Largest Ever Accuray Deal Will Provide More Cancer Patients in the United Kingdom (UK) Access to Advanced, Precise Radiation Treatments
How Rewarding Investors Believe These Medical Appliances and Equipment Stocks are? - Edwards Lifesciences, Stryker, Accuray, and ABIOMED
June 08, 2016
Accuray Incorporated (NASDAQ: ARAY), announced today that Joshua H. Levine, President and Chief Executive Officer, is scheduled to present at the Jefferies Healthcare Conference in New York, NY on...
Accuray Incorporated (NASDAQ: ARAY) announced today that the Company will host an Analyst and Investor Day on Friday, May 20, 2016 at the Lotte Palace Hotel in New York City.
Accuray Signs Long-Term Strategic Development and Supply Agreement with medPhoton for Volumetric Image Guidance Solutions for the CyberKnife® System
May 01, 2016
Collaboration Designed to Expand Clinical Versatility of the CyberKnife® System with Addition of medPhoton Novel Imaging Solution
Accuray Submits 510(k) Premarket Notification to FDA for Its Radixact™ Treatment Delivery System
April 26, 2016
Accuray Incorporated (NASDAQ: ARAY) announced today the submission of its 510(k) premarket notification with the Food and Drug Administration (FDA) for the company's Radixact™ Treatment Delivery...
Accuray Generates $105.3 Million in Third Quarter Revenues
April 26, 2016
Accuray Hosts Regional AERO Users' Meeting
April 21, 2016
Accuray Incorporated (NASDAQ: ARAY) will report results for its third quarter ended March 31, 2016 on April 26, 2016 after the market close. Management will host a conference call to review the results...
MedStar Georgetown University Hospital Treats 1,000 Prostate Cancer Patients with the CyberKnife® System
March 30, 2016
Meet the Biotech Company About to Turn the 120-Year-Old Cancer Radiation Industry on Its Head
March 17, 2016
Accuray and GE Capital Healthcare Equipment Finance Announce Healthcare Financing Collaboration Agreement
February 24, 2016
Accuray to Participate in the 36th Annual Cowen and Company Health Care Conference
February 23, 2016
Accuray Incorporated (Nasdaq: ARAY), announced today that Joshua H. Levine, President and Chief Executive Officer, is scheduled to present at the 36th Annual Cowen and Company Health Care Conference in...
Accuray Generates $108.9 Million in Second Quarter Revenues
January 28, 2016
Record Revenues Achieved as Commercial Execution Continues; Management Reaffirms Fiscal 2016 Guidance
Accuray Announces Repurchases of Convertible Debt
January 18, 2016
Accuray Incorporated (NASDAQ: ARAY) today announced that between January 11 and January 15, 2016, the company, in privately-negotiated transactions, had repurchased approximately $63.4 million in...
Accuray Announces First Radiation Therapy Systems Installed in Qatar, Latvia and Bulgaria
January 13, 2016
Premier Qatar, Latvian Cancer Centers to Offer Patients Treatment with the CyberKnife® System; Leading Bulgarian Hospital to Provide Treatment with the TomoTherapy® System
Accuray Closes $70 Million Straight Debt Financing
January 11, 2016
Accuray Incorporated (NASDAQ: ARAY) announced today it has closed a $70 million straight debt financing agreement with Cerberus Business Finance, LLC, an affiliate of Cerberus Capital Management, L.P....
Accuray Announces Preliminary Second Quarter Financial Results
January 10, 2016
Revenue Expected to be Approximately $107.5 Million; Gross Orders Expected to be Approximately $67 Million
Accuray Incorporated (NASDAQ: ARAY) will report results for its second quarter ended December 31, 2015 on January 28, 2016 after the market close. Management will host a conference call to review the...
Accuray Incorporated (Nasdaq: ARAY), announced today that Joshua H. Levine, president and chief executive officer, is scheduled to present at the 34th Annual J.P. Morgan Healthcare Conference in San...
Accuray Hosts First Regional Users' Meeting
December 16, 2015